| # | Title | Journal | Year | Citations |
|---|
| 1 | Biological roles of oligosaccharides: all of the theories are correct | Glycobiology | 1993 | 5,114 |
| 2 | Biological roles of glycans | Glycobiology | 2017 | 1,676 |
| 3 | New insights on trehalose: a multifunctional molecule | Glycobiology | 2003 | 1,577 |
| 4 | Human milk oligosaccharides: Every baby needs a sugar mama | Glycobiology | 2012 | 1,315 |
| 5 | Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds | Glycobiology | 2002 | 1,210 |
| 6 | History of lectins: from hemagglutinins to biological recognition molecules | Glycobiology | 2004 | 882 |
| 7 | A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds | Glycobiology | 2007 | 844 |
| 8 | Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites | Glycobiology | 2005 | 825 |
| 9 | Symbol Nomenclature for Graphical Representations of Glycans | Glycobiology | 2015 | 818 |
| 10 | Fucose: biosynthesis and biological function in mammals | Glycobiology | 2003 | 770 |
| 11 | Galectin-1: a small protein with major functions | Glycobiology | 2006 | 742 |
| 12 | Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation | Glycobiology | 2005 | 692 |
| 13 | Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family | Glycobiology | 2012 | 670 |
| 14 | Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide | Glycobiology | 2003 | 659 |
| 15 | Glycosidase inhibitors: update and perspectives on practical use | Glycobiology | 2003 | 644 |
| 16 | Optimal and consistent protein glycosylation in mammalian cell culture | Glycobiology | 2009 | 595 |
| 17 | Diversity in the sialic acids | Glycobiology | 1992 | 578 |
| 18 | Structures and mechanisms of glycosyltransferases | Glycobiology | 2006 | 572 |
| 19 | Amino-sugar glycosidase inhibitors: versatile tools for glycobiologists | Glycobiology | 1992 | 523 |
| 20 | The family of metazoan metal-independent β-galactoside-binding lectins: structure, function and molecular evolution | Glycobiology | 1993 | 496 |
| 21 | Siglecs—the major subfamily of I-type lectins | Glycobiology | 2006 | 490 |
| 22 | An evolving view of the eukaryotic oligosaccharyltransferase | Glycobiology | 2006 | 469 |
| 23 | Evolutionary considerations in relating oligosaccharide diversity to biological function | Glycobiology | 1999 | 465 |
| 24 | Formation of the glycan chains in the synthesis of bacterial peptidoglycan | Glycobiology | 2001 | 434 |
| 25 | All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases | Glycobiology | 2003 | 428 |
| 26 | Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 | Glycobiology | 2020 | 420 |
| 27 | Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics | Glycobiology | 2000 | 417 |
| 28 | High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans | Glycobiology | 2011 | 411 |
| 29 | Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin | Glycobiology | 2004 | 409 |
| 30 | Invited Commentary: A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 × 1012 structures for a reducing hexasaccharide: the Isomer Barrier to development of single-method saccharide sequencing or synthesis systems | Glycobiology | 1994 | 407 |
| 31 | Brain extracellular matrix | Glycobiology | 1996 | 405 |
| 32 | Dermatan sulfate: new functions from an old glycosaminoglycan | Glycobiology | 2002 | 397 |
| 33 | Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding | Glycobiology | 2003 | 391 |
| 34 | Comparison of the methods for profiling glycoprotein glycans—HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study | Glycobiology | 2007 | 382 |
| 35 | Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases | Glycobiology | 2002 | 378 |
| 36 | MINI REVIEW Keratan sulfate: structure, biosynthesis, and function | Glycobiology | 2000 | 373 |
| 37 | Ovarian Cancer is Associated with Changes in Glycosylation in Both Acute-Phase Proteins and IgG | Glycobiology | 2007 | 369 |
| 38 | Polysialylation: from bacteria to brains | Glycobiology | 1992 | 366 |
| 39 | Sialic acids in cancer biology and immunity | Glycobiology | 2016 | 364 |
| 40 | Nod factor structures, responses, and perception during initiation of nodule development | Glycobiology | 2002 | 363 |
| 41 | Fucosylation in prokaryotes and eukaryotes | Glycobiology | 2006 | 359 |
| 42 | N-Glycans in cancer progression | Glycobiology | 2008 | 358 |
| 43 | Lectin-like proteins in model organisms: implications for evolution of carbohydrate-binding activity | Glycobiology | 2001 | 355 |
| 44 | Plant protein glycosylation | Glycobiology | 2016 | 353 |
| 45 | Fc glycans of therapeutic antibodies as critical quality attributes | Glycobiology | 2015 | 346 |
| 46 | Focus on antivirally active sulfated polysaccharides: From structure–activity analysis to clinical evaluation | Glycobiology | 2009 | 344 |
| 47 | Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation | Glycobiology | 2001 | 341 |
| 48 | CAZymes Analysis Toolkit (CAT): Web service for searching and analyzing carbohydrate-active enzymes in a newly sequenced organism using CAZy database | Glycobiology | 2010 | 335 |
| 49 | Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types | Glycobiology | 2007 | 334 |
| 50 | Mycobacterial lipoarabinomannan: An extraordinary lipoheteroglycan with profound physiological effects | Glycobiology | 1998 | 333 |
